Children's Center for Digestive Healthcare

Atlanta, Georgia 30342

Use our guide to learn which trials are right for you!

We've found
8 trials
at this facility
Congenital Sucrase-isomaltase Deficiency CSID Clinical Trial
Congenital Sucrase-Isomaltase Deficiency (CSID) Genetic Prevalence Study (GPS)
Status: Enrolling
Updated: 6/10/2014
mi
from
Atlanta, GA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Clinical Study Comparing PillCamĀ® Crohn's Capsule Endoscopy to Ileocolonoscopy (IC) Plus MRE for Detection of Active CD in the Small Bowel and Colon in Subjects With Known CD and Mucosal Disease.
Status: Enrolling
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials
Eosinophilic Esophagitis (EoE) Clinical Trial
Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials